Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra S Potter

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Psychopharmacology|April 15, 2004
Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorderAlexandra S Potter, Paul A Newhouse
Pharmacology, Biochemistry, and Behavior|November 21, 2007
Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorderAlexandra S Potter, Paul A Newhouse
CNS Drugs|October 29, 2014
Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to dateAlexandra S Potter, Geoffrey Schaubhut, Megan Shipman
Pharmacology, Biochemistry, and Behavior|November 20, 2012
Rate dependent effects of acute nicotine on risk taking in young adults are not related to ADHD diagnosisKatherine K Ryan, Sarahjane L Dube, Alexandra S Potter
Behavioural Brain Research|November 4, 2006
Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?Alexandra S Potter, Paul A Newhouse, David J Bucci
Psychopharmacology|October 5, 2011
Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivityAlexandra S Potter, David J Bucci, Paul A Newhouse
Human Psychopharmacology|May 29, 2009
Effects of acute ultra-low dose mecamylamine on cognition in adult attention-deficit/hyperactivity disorder (ADHD)Alexandra S Potter, Katherine K Ryan, Paul A Newhouse
Preventive Medicine Reports|June 1, 2022
Persistently low readiness to vaccinate young children against COVID among vaccine adherent mothers in Vermont, USALeigh-Anne Cioffredi, Kaelyn L Kohlasch, Elina Thomas, et al.
Biological Psychiatry|July 17, 2013
AZD3480, a novel nicotinic receptor agonist, for the treatment of attention-deficit/hyperactivity disorder in adultsAlexandra S Potter, Geoffrey Dunbar, Emily Mazzulla, et al.
European Journal of Pharmacology|October 10, 2006
Nicotine administration enhances conditioned inhibition in ratsJill E MacLeod, Alexandra S Potter, Michael K Simoni, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Psychopharmacology|April 15, 2004
Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorderAlexandra S Potter, Paul A Newhouse
Pharmacology, Biochemistry, and Behavior|November 21, 2007
Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorderAlexandra S Potter, Paul A Newhouse
CNS Drugs|October 29, 2014
Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to dateAlexandra S Potter, Geoffrey Schaubhut, Megan Shipman
Pharmacology, Biochemistry, and Behavior|November 20, 2012
Rate dependent effects of acute nicotine on risk taking in young adults are not related to ADHD diagnosisKatherine K Ryan, Sarahjane L Dube, Alexandra S Potter
Behavioural Brain Research|November 4, 2006
Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?Alexandra S Potter, Paul A Newhouse, David J Bucci
Psychopharmacology|October 5, 2011
Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivityAlexandra S Potter, David J Bucci, Paul A Newhouse
Human Psychopharmacology|May 29, 2009
Effects of acute ultra-low dose mecamylamine on cognition in adult attention-deficit/hyperactivity disorder (ADHD)Alexandra S Potter, Katherine K Ryan, Paul A Newhouse
Preventive Medicine Reports|June 1, 2022
Persistently low readiness to vaccinate young children against COVID among vaccine adherent mothers in Vermont, USALeigh-Anne Cioffredi, Kaelyn L Kohlasch, Elina Thomas, et al.
Biological Psychiatry|July 17, 2013
AZD3480, a novel nicotinic receptor agonist, for the treatment of attention-deficit/hyperactivity disorder in adultsAlexandra S Potter, Geoffrey Dunbar, Emily Mazzulla, et al.
European Journal of Pharmacology|October 10, 2006
Nicotine administration enhances conditioned inhibition in ratsJill E MacLeod, Alexandra S Potter, Michael K Simoni, et al.
Pageof 4